UK launches programme to improve dementia clinical trial enrolment
The initiative will help clinicians find dementia patients eligible for clinical trials in the UK.
Therapy Area
Sanofi’s bispecific scores in respiratory diseases but fails in eczema
Alar Pharmaceuticals’ long-acting ketamine shows early potential in TRD
ACC 2026: Meta-analysis supports CagriSema as superior first-line therapy in obesity
Oric to advance prostate cancer drug to Phase III trials
Meningitis outbreak in UK suggests vigilance is required even if cases are rare
ACC 2026: pooled analysis supports early dapagliflozin use in acute HF care
2025 dominated in ALS research
